Back to Dividend Stocks
Eli Lilly and Company (LLY) logo

Eli Lilly and Company

S&P 500
LLY|Healthcare|Drug Manufacturers - General|$948.45|P/E 33.7|MCap 845.8B|NYSE

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

85/ 100Very Safe

LLY's dividend appears very safe. Strengths include a 22.1% earnings payout ratio & 53.9% fcf payout ratio. The dividend has been growing at a 15.18% 5-year CAGR.

Based on 14 of 15 metrics

Strengths

  • Earnings Payout Ratio: 22.1%Low earnings payout ratio leaves room to grow the dividend.
  • CFO Payout Ratio: 22.8%Operating cash flow strongly supports the payout.
  • Return on Equity: 107.5%Strong return on equity reflects efficient profit generation.

Risks

No material risks identified across rated metrics.

Payout & Coverage

Very Safe
Earnings Payout Ratio
22.1%Very Safe
FCF Payout Ratio
53.9%Safe
CFO Payout Ratio
22.8%Very Safe
Interest Coverage
N/AN/A

Balance Sheet

Caution
Net Debt / Total Assets
31.3%Caution
Current Ratio
1.5xCaution
Debt-to-Equity
139.0Caution

Profitability

Very Safe
Return on Equity
107.5%Very Safe
Operating Margin
49.4%Very Safe
Gross Margin
81.9%Very Safe
Profit Margin Stability
ModerateCaution

Dividend Track Record

Very Safe
Dividend Streak
11+ yrsVery Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
15.2%Very Safe
Earnings Stability
GrowingVery Safe

About Eli Lilly and Company

Eli Lilly and Company is a leading pharmaceutical company engaged in the discovery, development, manufacture, and sale of human pharmaceutical products. It focuses on innovative medicines addressing critical health needs in areas such as diabetes, oncology, immunology, neuroscience, obesity, cardiovascular diseases, cancer, and other therapeutic categories including bone muscle joint disorders, endocrine conditions, dermatology, autoimmune diseases, sleep apnea, migraine, and Alzheimer's disease. The company offers treatments like insulins, GLP-1 therapies for diabetes and obesity, oncology drugs, immunologic agents, and neuroscience products. Eli Lilly and Company supports access initiatives through partnerships for technology transfer and API supply to manufacturers in low- and middle-income countries, enhancing availability of insulins and other therapies in regions like Africa and Bangladesh. It maintains a robust research and development pipeline targeting non-communicable diseases, with late-stage projects in diabetes, cardiovascular, and oncology areas. Founded in 1876 and headquartered in Indianapolis, Indiana, Eli Lilly and Company plays a significant role in the global health technology sector by delivering therapies that improve patient outcomes across diverse medical fields.

Dividend Overview

Dividend Yield

0.66%

Annual Dividend

$6.23

Frequency

Quarterly

Payout Ratio

22.13%

FCF Payout Ratio

53.88%

Stock Price

$948.45

52-Week Range

$623.78 $1133.95

Dividend History (2016–2025)

LLY annual dividend per share and yield history

Earnings & Profitability

LLY earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

May 15, 2026

Next Payment Date

June 10, 2026

Dividend Growth

3-Year Dividend CAGR

15.24%

5-Year Dividend CAGR

15.18%

10-Year Dividend CAGR

11.61%

3-Year Total Growth

53.06%

5-Year Total Growth

102.70%

10-Year Total Growth

200.00%

Income Calculator

LLY Dividend Calculator

Total Investment

$94,845.00

Annual Income

$623.00

Quarterly Income

$155.75

Monthly Income

$51.92

Similar Dividend Stocks

StockYield5Y CAGRPrice
Eli Lilly and Company (LLY) logo
LLY
0.66%15.18%$948.45
AbbVie Inc. (ABBV) logo
ABBV
3.35%6.81%$201.55
Amgen Inc. (AMGN) logo
AMGN
2.95%8.27%$331.70
Gilead Sciences Inc. (GILD) logo
GILD
2.43%3.04%$131.33
Johnson & Johnson (JNJ) logo
JNJ
2.29%5.25%$221.32
Merck & Co., Inc. (MRK) logo
MRK
2.98%6.75%$111.38
Pfizer Inc. (PFE) logo
PFE
6.70%3.59%$25.68

Frequently Asked Questions

What is LLY's current dividend yield?
Eli Lilly and Company (LLY) currently has a dividend yield of 0.66%, based on a stock price of $948.45 and an annual dividend of $6.23.
When is LLY's next dividend payment date?
LLY's next ex-dividend date is 2026-05-15 and the next payment date is 2026-06-10. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does LLY pay in dividends per year?
Eli Lilly and Company paid $6.00 per share in annual dividends in 2025. The dividends are paid quarterly.
Has LLY been increasing its dividend?
Eli Lilly and Company has grown its dividend at a 5-year CAGR of 15.18% and a 10-year CAGR of 11.61%.
Is LLY's dividend safe?
Eli Lilly and Company has a payout ratio of 22.13%. Its free cash flow payout ratio is 53.88%. A payout ratio below 60% is generally considered sustainable.
How is LLY's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Eli Lilly and Company's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track LLY Dividends with OnlyDividends

What will LLY actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.